USPTO trademark

PRIMEONE

Under examinationUSPTOWord markClass 9Class 35Class 36Class 44+1

"PRIMEONE" is a word mark owned by Prime Therapeutics LLC, filed at the USPTO on July 28, 2026. It is under examination and covers classes 9, 35, 36, 44 and 45.

View Prime Therapeutics LLC portfolioGet this data via the API
Official USPTO record
PRIMEONE trademark as filed
As filed with the USPTO
Status
Under examination
Since July 28, 2026
Filed
July 28, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50018041
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
5 classes
Ownership

Who owns PRIMEONE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Prime Therapeutics LLC

Eagan, United States

45 trademarks in the portfolioView company

Representative

Felicia J. Boyd

Norton Rose Fulbright US LLP

Goods and services

What the mark covers

The products and services PRIMEONE is filed for, grouped by Nice class.

  • Downloadable mobile applications for reviewing medical and prescription drug benefits and coverage, reviewing prescription drug utilization and spending, managing drug prescriptions, managing drug prescription purchase and delivery options, accessing educational information on prescription drugs, finding a pharmacy, finding prescription drug pricing, comparing prescription drug pricing, receiving notifications on prescription drug pricing and savings, and tracking prior authorizations for prescription drugs

  • Pharmaceutical cost management services; business data analyzing and reporting services in the fields of pharmaceuticals; providing information in the field of business management of prescription drug savings; business management consulting relating to prescription drug costs using analytic and predictive models applied to medical and pharmacy data; consulting services in the field of cost management of drug therapies through medical cost management

  • Pharmacy benefit management services; organizing and administering preferred provider plans for a network of pharmacy providers

  • Pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; health care coordination services, namely, coordinating medical services and access to specialty drug therapies for patients

  • Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication and medical services

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. New application office supplied data entered
  2. Application filing receipt mailed
  3. New application entered
FAQ

About PRIMEONE

Who owns the trademark "PRIMEONE"?

The USPTO trademark "PRIMEONE" (application 50018041) is owned by Prime Therapeutics LLC.

What is the status of "PRIMEONE"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull PRIMEONE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019fae01-f8e4-7659-b4a8-9265ef63f32d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019fae01-f8e4-7659-b4a8-9265ef63f32d",
  "object": "trademark",
  "mark_text": "PRIMEONE",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50018041",
  "filing_date": "2026-07-28",
  "nice_classes": [
    9,
    35,
    36,
    44,
    45
  ],
  "owners": [
    {
      "name": "Prime Therapeutics LLC",
      "entity_id": "ent_019eb6fe-75bc-7498-b91a-6bffe9e5b38d"
    }
  ]
}